Identification of fluoroquinolone-resistant extended-spectrum β-lactamase (CTX-M-8)-producing Escherichia coli ST224, ST2179 and ST2308 in buffalo (Bubalus bubalis)

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 10, 2014, Pages 2866-2869

  Aizawa, Juliana ^a   Neuwirt, Natalie ^a   Barbato, Leandro ^a   Neves, Patrícia R ^a   Leigue, Lucianne ^a   Padilha, João ^a   de Castro, Antonio F Pestana ^a   Gregory, Lilian ^a   Lincopan, Nilton ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; CMY 2; E. coli; ESBLs; MLST; Multidrug resistant; PAmpC; PMQR

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 8; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTIOFUR; CIPROFLOXACIN; COTRIMOXAZOLE; ENROFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIAL MUTATION; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES ANALYSIS; GENOTYPE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WATER BUFFALO; ANIMAL; BOVINE; BUFFALO; DRUG EFFECTS; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BUFFALOES; CATTLE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLUOROQUINOLONES;

EID: 84920922432     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku218     Document Type: Letter

References (12)

1. Eller C, Leistner R, Guerra B et al. Emergence of extended-spectrum β-lactamase (ESBL) CTX-M-8 in Germany. J Antimicrob Chemother 2014; 69: 562-4.
2. Bonnet R, Sampaio JLM, Labia R et al. A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 2000; 44: 1936-42.
3. Peirano G, Laupland KB, Gregson DB et al. Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med 2011; 18: 299-303.
4. Vinue L, Saenz Y, Martinez S et al. Prevalence and diversity of extendedspectrum β-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 2009; 15: 954-7.
5. Dhanji H, Murphy NM, Doumith M et al. Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK. J Antimicrob Chemother 2010; 65: 2534-7.
6. Egervärn M, Börjesson S, Byfors S et al. Escherichia coli with extendedspectrum β-lactamases or transferable AmpC β-lactamases and Salmonella on meat imported into Sweden. Int J Food Microbiol 2014; 171: 8-14.
7. Sennati S, Santella G, Di Conza J et al. Changing epidemiology of extended-spectrum β-lactamases in Argentina: emergence of CTX-M-15. Antimicrob Agents Chemother 2012; 56: 6003-5.
8. Woerther PL, Angebault C, Jacquier H et al. Characterization of fecal extended-spectrum-β-lactamase-producing Escherichia coli in a remote community during a long time period. Antimicrob Agents Chemother 2013; 57: 5060-6.
9. Kawamura K, Goto K, Nakane K et al. Molecular epidemiology of extended-spectrum β-lactamases and Escherichia coli isolated from retail foods including chicken meat in Japan. Foodborne Pathog Dis 2014; 11: 104-10.
10. Kiiru J, Kariuki S, Goddeeris BM et al. Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period. BMC Microbiol 2012; 12: 155.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals-Third Edition: Approved Standard M31-A3. CLSI, Wayne, PA, USA, 2008.
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. CLSI, Wayne, PA, USA, 2013.